Last year, Johns Hopkins University and MedImmune announced their collaboration on a unique new initiative, the Johns Hopkins-MedImmune Scholars Program. The program has just selected its first Ph.D. candidates for a curriculum that will prepare them for careers in the biopharma industry.
Inez Lam and Natalia Majewska, both first-year Johns Hopkins University Ph.D. students, will participate in the five-year program, the first-of-its-kind in the United States, to gain a better understanding of the process and challenges of drug discovery and development. Upon completion, they will receive a traditional Ph.D. from The Johns Hopkins University.
{iframe}https://ventures.jhu.edu/first-candidates-selected-for-johns-hopkins-medimmune-scholars-program/{/iframe}